The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Reported Medication Use in the Neonatal Intensive Care Unit: Data From a Large National Data Set
Abstract
OBJECTIVES. The objectives were (1) to identify the drugs reported most commonly during NICU care, (2) to examine how different methods of documenting drug use could influence prioritization of drugs for future research aimed at evaluating safety and efficacy, (3) to describe the demographic differences in the population samples for some specific medications, (4) to identify which reported medications are used for patient populations with >20% mortality rates, and (5) to examine how reports of drug use change over time. METHODS. A retrospective review of a large national data set was performed. RESULTS. The 10 medications reported most commonly for the NICU were ampicillin, gentamicin, ferrous sulfate, multivitamins, cefotaxime, caffeine citrate, furosemide, vancomycin, surfactant, and metoclopramide. Medications used for patient populations with >20% mortality rates included amphotericin, clonazepam, dobutamine, epinephrine, ethacrynic acid, insulin, lidocaine, metolazone, milrinone, inhaled nitric oxide, nitroglycerin, octreotide, pancuronium, phenytoin, sodium nitroprusside, sodium polystyrene sulfonate (Kayexalate), tris-hydroxymethylaminomethane acetate buffer, and tolazoline. Several of these drugs (eg, amphotericin B and bumetanide) were used primarily for extremely premature neonates, and this usage might explain the high mortality rates for the population of neonates treated with these medications. Other medications (clonazepam, milrinone, inhaled nitric oxide, and phenytoin) were used primarily for near-term and term infants. The explanation for the high mortality rates for these neonates is less clear and may be related primarily to the severity of illness for which the medications are used. Utilization rates for several different medications (eg, cisapride, metoclopramide, and dexamethasone) changed by >50% during the past 5 years. CONCLUSIONS. Data reported here are the first from a large national data set on the use of different medications for neonates admitted for intensive care and should be helpful in establishing priority agendas for future drug studies in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Kaushal, R. (2001) · JAMA · doi:10.1001/jama.285.16.2114 · Cited by 1,917
Fortescue, E. B., Kaushal, R., Landrigan, C. P., McKenna, K. J., Clapp, M. D., Federico, F., Goldmann, D. A., & Bates, D. W. (2003) · Pediatrics · doi:10.1542/peds.111.4.722 · Cited by 462
Intrauterine growth restriction increases morbidity and mortality among premature neonates
Garite, T. J., Clark, R., & Thorp, J. A. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.036 · Cited by 446
Self-citationNecrotizing Enterocolitis Among Neonates in the United States
Guthrie, S. O., Gordon, P. V., Thomas, V., Thorp, J. A., Peabody, J., & Clark, R. H. (2003) · Journal of Perinatology · doi:10.1038/sj.jp.7210892 · Cited by 386
Self-citationPonsky, T. A. (2004) · JAMA · doi:10.1001/jama.292.16.1977 · Cited by 271
Basic and Therapeutic Aspects of Perinatal Pharmacology
(1976) · Archives of Disease in Childhood · doi:10.1136/adc.51.11.904-a · Cited by 250
Newman, K., Ponsky, T., Kittle, K., Dyk, L., Throop, C., Gieseker, K., Sills, M., & Gilbert, J. (2003) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2003.50111 · Cited by 240
Empirical Therapy for Neonatal Candidemia in Very Low Birth Weight Infants
Benjamin, D. K., DeLong, E. R., Steinbach, W. J., Cotton, C. M., Walsh, T. J., & Clark, R. H. (2003) · Pediatrics · doi:10.1542/peds.112.3.543 · Cited by 199
Self-citationAn Update on the Therapeutic Orphan
Wilson, J. T. (1999) · Pediatrics · doi:10.1542/peds.104.s3.585 · Cited by 171
A Survey of the Use of Off-Label and Unlicensed Drugs in a Dutch Children's Hospital
't Jong, G. W., Vulto, A. G., de Hoog, M., Schimmel, K. J. M., Tibboel, D., & van den Anker, J. N. (2001) · Pediatrics · doi:10.1542/peds.108.5.1089 · Cited by 166
Benjamin, D. K., DeLong, E. R., Cotten, C. M., Garges, H. P., Steinbach, W. J., & Clark, R. H. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211068 · Cited by 138
Self-citationReported Adverse Drug Events in Infants and Children Under 2 Years of Age
Moore, T. J., Weiss, S. R., Kaplan, S., & Blaisdell, C. J. (2002) · PEDIATRICS · doi:10.1542/peds.110.5.e53 · Cited by 137
Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands
Jong, G. W. ‘., van der Linden, P., Bakker, E., van der Lely, N., Eland, I. A., Stricker, B. H. C., & van den Anker, J. N. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0479-9 · Cited by 101
Risk Factors for Unlicensed and Off-Label Drug Use in Children Outside the Hospital
Schirm, E., Tobi, H., & den Berg, L. T. W. D. J. (2003) · PEDIATRICS · doi:10.1542/peds.111.2.291 · Cited by 99
Pharmacokinetic and Pharmacodynamic Data Collection in Children and Neonates: A Quiet Frontier
Gilman, J. T., & Gal, P. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223010-00001 · Cited by 93
Unlicensed and Off-Label Medication Use in a Neonatal Intensive Care Unit: A Prospective Study
Barr, J., Brenner-Zada, G., Heiman, E., Pareth, G., Bulkowstein, M., Greenberg, R., & Berkovitch, M. (2002) · American Journal of Perinatology · doi:10.1055/s-2002-23557 · Cited by 82
Thorp, J. A., Jones, P. G., Peabody, J. L., Knox, E., & Clark, R. H. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01657-x · Cited by 27
Self-citation
Cited by
Cotten, C. M., Taylor, S., Stoll, B., Goldberg, R. N., Hansen, N. I., Sánchez, P. J., Ambalavanan, N., Benjamin, D. K., & for the NICHD Neonatal Research Network (2009) · Pediatrics · doi:10.1542/peds.2007-3423 · Cited by 974
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073679 · Cited by 948
Impact of antibiotics on the human microbiome and consequences for host health
Patangia, D. V., Anthony Ryan, C., Dempsey, E., Paul Ross, R., & Stanton, C. (2022) · MicrobiologyOpen · doi:10.1002/mbo3.1260 · Cited by 754
Kuppala, V. S., Meinzen-Derr, J., Morrow, A. L., & Schibler, K. R. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.05.033 · Cited by 613
Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome
Gibson, M. K., Wang, B., Ahmadi, S., Burnham, C.-A. D., Tarr, P. I., Warner, B. B., & Dantas, G. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.24 · Cited by 457
Metadata
- Authors
- Clark, R. H., Bloom, B. T., Spitzer, A. R., & Gerstmann, D. R.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2006-06-01
- Volume
- 117
- Issue
- 6
- Pages
- 1979-1987
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1986250576
- Cited by
- 416
- References
- 17
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.